ClinConnect ClinConnect Logo
Search / Trial NCT04201548

Different Modalities of Exercise Training in COPD With Chronic Respiratory Failure (CRF)

Launched by ISTITUTI CLINICI SCIENTIFICI MAUGERI SPA · Dec 16, 2019

Trial Information

Current as of August 02, 2025

Completed

Keywords

ClinConnect Summary

Advanced (Chronic Obstructive Pulmonary Disease) COPD is a condition with a negative prognosis that causes symptoms such as wheezing and fatigue that dramatically reduce the quality of life of the person with the disease.

Typically, the advanced stage of COPD is characterized by a fluctuating pattern and recurrent hospitalizations, and by a vicious circle in which dyspnoea increases and exercise tolerance reduces, which in turn causes depression and associated social isolation, low quality of life and increased risk of death.

Muscle dysfunction in these patients contributes together with ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age\> 50 years
  • clinical definition of COPD according to GOLD guidelines (10) with FEV1 / FVC G 70% and FEV1 \<50% of the above
  • PaO2 in air-ambient lower than 60 mmHg evaluated through arterial blood gas analysis
  • oxygen therapy prescription for more than 18 hours/ day for at least one month
  • clinical stable condition
  • Exclusion Criteria:
  • presence of pulmonary diseases other than COPD
  • respiratory tract infections in the last 4 weeks
  • termination

About Istituti Clinici Scientifici Maugeri Spa

Istituti Clinici Scientifici Maugeri S.p.A. is a prestigious Italian healthcare organization dedicated to advancing medical research and clinical practice. With a strong focus on patient-centered care, the institution integrates innovative clinical trials into its comprehensive services, fostering collaboration between researchers and healthcare professionals. Known for its commitment to high-quality standards and ethical practices, Istituti Clinici Scientifici Maugeri S.p.A. plays a pivotal role in the development of new therapies and treatment modalities, contributing significantly to the global medical community and enhancing patient outcomes.

Locations

Lumezzane, Brescia, Italy

Patients applied

0 patients applied

Trial Officials

Mara Paneroni, MSc, PT

Principal Investigator

Istituti Clinici Scientifici Maugeri

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials